Skip to main content

Sunscreen Agents

0
Pipeline Programs
2
Companies
11
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Bayer
BayerLEVERKUSEN, Germany
10 programs
BAY 987516N/A1 trial
BAY 987516N/A1 trial
BAY 987517N/A1 trial
BAY 987519N/A1 trial
BAY 987519N/A1 trial
+5 more programs
Active Trials
NCT02872207Completed40Est. Feb 2015
NCT02872246Completed11Est. Jul 2015
NCT02857725Completed12Est. Jun 2015
+7 more trials
Innovation Pharmaceuticals
1 program
Day Gel-0120N/A1 trial
Active Trials
NCT05004168Completed20Est. Sep 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Innovation PharmaceuticalsDay Gel-0120
BayerBAY 987519, SPF 50, Y51-002
BayerBAY987516
BayerBAY 987519
BayerBAY 987519
BayerBAY 987516
BayerBAY 987517
BayerSPF 50 Y65 110
BayerBAY 987516
BayerBAY98751
BayerBAY987516, Y55-170

Clinical Trials (11)

Total enrollment: 328 patients across 11 trials

NCT05004168Innovation PharmaceuticalsDay Gel-0120

Sun Protection Factor (SPF) / UVA Protection Factor Study

Start: Sep 2020Est. completion: Sep 202020 patients
N/ACompleted
NCT02857478BayerBAY 987519, SPF 50, Y51-002

Supervised Outdoor-Use Test to Assess the Safety of a Sunscreen C-Spray on Sport Users

Start: Jun 2015Est. completion: Jun 201598 patients
N/ACompleted
NCT02885805BayerBAY987516

Sun Protection Factor (SPF) Efficacy Assay

Start: Jun 2015Est. completion: Jul 201511 patients
N/ACompleted
NCT02872233BayerBAY 987519

Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) Assay

Start: May 2015Est. completion: Jun 20156 patients
N/ACompleted
NCT02857738BayerBAY 987519

Sun Protection Factor (SPF) - Static and Water Resistant Assay

Start: May 2015Est. completion: Jun 201512 patients
N/ACompleted
NCT02872246BayerBAY 987516

Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) - Assay

Start: May 2015Est. completion: Jul 201511 patients
N/ACompleted
NCT02857725BayerBAY 987517

Sun Protection Factor (SPF) Assay

Start: May 2015Est. completion: Jun 201512 patients
N/ACompleted
NCT02802930BayerSPF 50 Y65 110

Test the Phototoxicity of Sunscreen Products

Start: Apr 2015Est. completion: Apr 201532 patients
N/ACompleted
NCT02872207BayerBAY 987516

Evaluation of the Stinging Potential in Human Eyes

Start: Feb 2015Est. completion: Feb 201540 patients
N/ACompleted
NCT02869113BayerBAY98751

Evaluation of the Stinging Potential of Sunscreen Products in Human Eyes

Start: Jan 2015Est. completion: Jan 201565 patients
N/ACompleted
NCT02872194BayerBAY987516, Y55-170

Evaluation of the Stinging Potential of Products in Human Eyes

Start: Sep 2014Est. completion: Sep 201421 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.